Human prostatic cell line PNT1A, a useful tool for studying androgen receptor transcriptional activity and its differential subnuclear localization in the presence of androgens and antiandrogens

Molecular and Cellular Endocrinology

Volumn 184, Issue 1-2, 2001, Pages 13-24

  Avancès, Christophe ^a,d   Georget, Virginie ^a   Térouanne, Béatrice ^a   Orio Jr , Francesco ^a   Cussenot, Olivier ^c   Mottet, Nicolas ^d   Costa, Pierre ^d   Sultan, Charles ^a,b  

^a INSERM   (France)

^b LAPEYRONIE HOSPITAL   (France)

^c SAINT LOUIS HOSPITAL   (France)

^d Hôpital G Doumergue   (France)

Author keywords

Antiandrogen; DU 145 cells; EGFP; Human androgen receptor; PNT1A cells

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANTIANDROGEN; BICALUTAMIDE; CYPROTERONE ACETATE; HYDROXYFLUTAMIDE;

ARTICLE; CELL LINE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE EPITHELIUM; REPORTER GENE; TRANSCRIPTION REGULATION;

ACTIVE TRANSPORT, CELL NUCLEUS; ANDROGEN ANTAGONISTS; ANDROGENS; CELL NUCLEUS; GENES, REPORTER; HUMANS; MALE; PROSTATE; RECEPTORS, ANDROGEN; RECOMBINANT FUSION PROTEINS; TRANS-ACTIVATION (GENETICS); TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0035955881     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(01)00669-4     Document Type: Article

References (39)

1. The specific binding of estrogens and androgens to the nuclear matrix of sex hormone responsive tissues
2. Cyproterone. A review of its pharmacology and therapeutic efficacy in prostate cancer
3. Effects of antiandrogens on transformation and transcription activation of wild-type and mutated (LNCaP) androgen receptors
4. Androgens are not a direct requirement for the proliferation of human prostatic epithelium in vitro
5. 5 alpha-reductase activity in cultured epithelial and stromal cells from normal and hyperplastic human prostates-effect of finasteride (Proscar), a 5 alpha-reductase inhibitor
6. Steroid-growth factor interaction in human prostate cancer. 2. Effects of transforming growth factors on androgen metabolism of prostate cancer cells
7. Immortalization of human adult normal prostatic epithelial cells by liposomes containing large T-SV40 gene
8. Testosterone and 5 alpha-dihydrotestosterone interact differently with the androgen receptor to enhance transcription of the MMTV-CAT reporter gene
9. Subcellular localization of mineralocorticoid receptors in living cells: effects of receptor agonists and antagonists
10. Stable transfection of androgen receptor and MMTV-CAT into mammalian cells: inhibition of CAT expression by anti-androgens
11. Trafficking of the androgen receptor in living cells with fused green fluorescent protein-androgen receptor
12. Trafficking of androgen receptor mutants fused to green fluorescent protein: a new investigation of partial androgen insensitivity syndrome
13. Trafficking of the androgen receptor
14. Testosterone at high concentrations interacts with the human androgen receptor similarly to dihydrotestosterone
15. Visualization of glucocorticoid receptor translocation and intranuclear organization in living cells with a green fluorescent protein chimera
16. Androgen receptor phosphorylation, turnover, nuclear transport, and transcriptional activation. Specificity for steroids and antihormones
17. Distinguishing androgen receptor agonists and antagonists: distinct mechanisms of activation by medroxyprogesterone acetate and dihydrotestosterone
18. Deoxyribonucleic acid-binding ability of androgen receptors in whole cells: implications for the actions of androgens and antiandrogens
19. Effects of antiandrogens on chromatin remodeling and transcription of the integrated mouse mammary tumor virus promoter
20. A novel substitution (Leu707Arg) in exon 4 of the androgen receptor gene causes complete androgen resistance
21. Phenotypic and genotypic characterization of commonly used human prostatic cell lines
22. Delta5-androstenediol is a natural hormone with androgenic activity in human prostate cancer cells
23. Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cells
24. A C619Y mutation in the human androgen receptor causes inactivation and mislocalization of the receptor with concomitant sequestration of SRC-1 (steroid receptor coactivator 1)
25. Localization, trafficking, and temperature-dependence of the Aequorea green fluorescent protein in cultured vertebrate cells
26. Specific recognition of androgens by their nuclear receptor: a structure-function study
27. Coregulator small nuclear RING finger protein (SNURF) enhances Sp1- and steroid receptor-mediated transcription by different mechanisms
28. Constitutive expression of FGF2/bFGF in non-tumorigenic human prostatic epithelial cells results in the acquisition of a partial neoplastic phenotype
29. FGF7/KGF triggers cell transformation and invasion on immortalised human prostatic epithelial PNT1A cells
30. Subnuclear trafficking of estrogen receptor-alpha and steroid receptor coactivator-1
31. A stable prostatic bioluminescent cell line to investigate androgen and antiandrogen effects
32. Dynamics of intracellular movement and nucleocytoplasmic recycling of the ligand-activated androgen receptor in living cells
33. Characterization of polyclonal antibodies against the N-terminal domain of the human androgen receptor
34. Domains of the human androgen receptor and glucocorticoid receptor involved in binding to the nuclear matrix
35. Rapid and sensitive reporter gene assays for detection of antiandrogenic and estrogenic effects of environmental chemicals
36. Androgen receptor localisation and turnover in human prostate epithelium treated with the antiandrogen, casodex
37. Immortalized and tumorigenic adult human prostatic epithelial cell lines: characteristics and applications. Part I. Cell markers and immortalized nontumorigenic cell lines
38. Lipofection-mediated immortalization of human prostatic epithelial cells of normal and malignant origin using human papillomavirus type 18 DNA